CTI Clinical Trials

Moving Medicine Forward

Science EN ↓ 83 episódios

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

Não deixe de visitar o site do podcast e apoiar quem o produz: www.ctifacts.com

Autor

CTI Clinical Trials

Categoria

Science

Site do podcast

www.ctifacts.com

Último episódio

18 de nov de 2026

Onde ouvir?

Podcasts no app Replaio Radio Em breve

Os podcasts estão chegando ao app. Instale agora e seja o primeiro a descobrir um jeito totalmente novo de curtir podcasts

Baixe no Google Play Instale grátis Android 10 mi+ downloads · nota 4,7+ iOS em breve

Episódios

Giving Back, Growing Together: How CTI Cares Builds Connection Through Community 18.11.2026

On this episode of Moving Medicine Forward , Jamie Glavic, Global Program Lead for CTI Cares, and Flavia Nascimento, LATAM Chair, reflect on how CTI Cares has grown into a global, employee-led program. They highlight memorable initiatives from 2026, share how employees bring local perspectives to the program, and discuss what’s ahead for CTI Cares in 2027.   00:49 CTI Cares across five global regi...

Inspiring STEM Careers in the Classroom: A Conversation with Adopt A Class 11.11.2026

On this episode of Moving Medicine Forward , Sonya Fultz, CEO of Adopt A Class , and Halle Raicevich, Research Associates Manager at CTI, discuss how early exposure can introduce students to careers in STEM and clinical research. They share how Adopt A Class connects students with local employers through classroom experiences that introduce new career possibilities. 00:00 Introduction to Adopt A C...

Rethinking Neurology: From Broad Diagnoses to Targeted Treatments 04.11.2026

In this episode of Moving Medicine Forward , Dr. Matthew Holtzman, Medical Director and neurologist at CTI CRC Michigan, joins Tim Schroeder, Executive Chairman and Founder of CTI, to explore emerging developments in neurology and the growth of CTI’s clinical research site network. They also discuss the complexities of recruiting patients for rare and neurological conditions and how increasingly p...

More Than Kidney Function: Designing Research for the Whole Patient 29.10.2026

Kidney disease is more than numbers on a chart. It can reshape a patient’s independence, family life, work, and future. In this episode, Dr. Ammar Tabikh, Senior Medical Director at CTI, draws on his experience in nephrology, transplantation, and clinical development to explore what it means to keep the whole patient at the center of kidney research. From more targeted treatments and thoughtful tr...

Freedom in Motion: How Chair Force 1 Supports Families Living with ALS 21.10.2026

What if a wheelchair-accessible van could give a family more than transportation? What if it could restore freedom, connection, and hope? In this episode of Moving Medicine Forward , host Jeremy Schrand speaks with Tony Bunce of Chair Force 1 Foundation and renowned neurosurgeon Dr. John Tew about the challenges of living with ALS and the life-changing impact of accessible mobility. Together, they...

Training Here, Staying Here: Building Northern Kentucky's Future Physician Workforce 14.10.2026

What does it take to build a healthier future for Northern Kentucky? On this episode of Moving Medicine Forward , we sit down with Dr. Holly Danneman, Associate Dean of the University of Kentucky College of Medicine Northern Kentucky Campus , to discuss how expanding medical education opportunities in the region can help address physician shortages, strengthen the local healthcare workforce, and i...

Connecting Data, Accelerating Decisions: Inside conneCTIva Lab Insights 07.10.2026

As clinical trials become increasingly complex, sponsors and study teams need faster access to the data that drives critical decisions. In this episode of Moving Medicine Forward , host Jeremy Schrand sits down with Kimberly Uptgraft, Vice President of Global Laboratory Services, and Rob Schumacher, Senior Director of Clinical Data Systems & Data Management at CTI, to discuss conneCTIva Lab In...

The Future is Cellular: Optieum Bio’s Next-Generation Approach to Glioblastoma 01.10.2026

Glioblastoma remains one of the most aggressive and difficult-to-treat forms of brain cancer, with recurrence posing a significant challenge for patients and researchers alike. In this episode of Moving Medicine Forward , Jeremy Schrand sits down with Moya Daniels, Vice President, Head of Regulatory and QA at Optieum Biotechnologies, to discuss the company's novel CAR-T cell therapy program, O...

One Mission, Many Journeys: Celebrating 27 Years of CTI 24.09.2026

As CTI celebrates 27 years of moving medicine forward, Hadley Decker, Senior Director, Global Training and Development, and Natiq Fazlani, Research Associate, share their unique career journeys at CTI. Through the lens of two employees at very different stages of their careers, they discuss professional growth, the value of curiosity, and the culture that continues to shape CTI's mission of ad...

More Time, More Options, More Hope: The Alzheimer's Association's Roadmap for Early Screening 17.09.2026

Alzheimer's disease affects millions of individuals and families, yet many people remain unaware of the critical role early detection can play in improving outcomes. In this episode, host Jeremy Schrand is joined by Andrew Pytlik and Patti Hahn of the Alzheimer's Association to discuss the growing importance of cognitive screening, advances in diagnostic testing, and the steps individuals...

Funding the Future: Closing Critical Gaps in Childhood Cancer Research 10.09.2026

Childhood cancer research faces unique challenges, from limited funding opportunities to fewer treatment options compared to adult cancers. In this episode of Moving Medicine Forward , host Jeremy Schrand is joined by Jill Brink, Executive Director of CancerFree KIDS, Dr. Meisam Nami of Cincinnati Children's, and Dr. Ezgi Elmas of CARTx Therapeutics to discuss how early-stage funding is helpin...

MMF Rewind | Building Better Clinical Trials: Study Start-Up, Patients, and Global Data 02.09.2026

This week, we're revisiting a previous conversation with Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient-centered decision-making, biometrics strategy, and g...

Stronger Together: Families, Researchers, and CancerFree KIDS 27.08.2026

Childhood cancer research advances through the combined efforts of families, researchers, advocates, and donors. In this episode, Matt Robinson of CancerFree KIDS and Dr. Lindy Miles of Cincinnati Children's discuss how early-stage research funding, clinical trials, and community support help bring new treatments to children with cancer. Matt shares his family's experience navigating leuke...

New Path, Same Purpose: Dedicated to Advancing Transplant Research 20.08.2026

After nearly 40 years caring for transplant patients and more than 25 years in clinical research, Dr. Helio Tedesco has made a unique transition from investigator to CRO medical leader. In this episode of Moving Medicine Forward , Dr. Tedesco reflects on the evolution of transplantation medicine, the challenges patients face before and after transplant, and why clinical research remains essential...

Chill, Not Kill: How Quell Therapeutics is Reimagining Cell Therapy 14.08.2026

In this episode of Moving Medicine Forward , Jeremy Schrand is joined by Luke Devey, Chief Medical Officer at Quell Therapeutics, and Savannah Doliboa, Chief Commercial Officer at CTI, to discuss how engineered regulatory T cell therapies are being developed to “chill, not kill” the immune system. The conversation explores Quell Therapeutics’ approach to Treg cell therapy, the complexity of launch...

Beyond the Fine Print: How Legal Affairs Enables Clinical Research 05.08.2026

Ian Hennessey, Vice President & General Counsel at CTI, joins Moving Medicine Forward to discuss the critical role legal affairs plays in advancing global clinical research. From navigating complex regulations and supporting trial operations to evaluating emerging technologies like AI, Ian shares how legal teams help organizations innovate responsibly while protecting patients and empowering s...

Inside Pharmacovigilance: Detecting Risks, Protecting Patients 29.07.2026

What happens behind the scenes to ensure new therapies are safe for patients? In this episode of Moving Medicine Forward , we are joined by John Kane, Vice President of Pharmacovigilance and Safety Services at CTI, to explore the critical role of drug safety throughout the clinical development process. John shares how safety teams collect and evaluate adverse event data, navigate complex global re...

Building Better Clinical Trials: Study Start-Up, Patients, and Global Data 23.07.2026

What does it take to set a complex global clinical trial up for success? In this episode of Moving Medicine Forward , we are joined by Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and stu...

From Australia to China: CTI's APAC Growth Journey 15.07.2026

Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly complex global environment. In this episode, Pavels Anetko, Director of Clinical Operations and Clinical Project Management at CTI, shares insights from across the region, including Australia's strengths in early phase studies a...

ALK Positive: How Patients are Driving Research 08.07.2026

Summer Farmen and Jeff Sturm share their personal cancer journeys and the mission behind ALK Positive, CTI’s Q3 Charity of the Quarter. ALK Positive is a patient-driven organization dedicated to improving outcomes for individuals living with ALK-positive cancer. Together, they discuss how they became advocates within a global patient community, the importance of genetic testing and second opinions...

MMF Rewind | CTI's Next Chapter: A Conversation with Jon Koch and Brian Lawrence 01.07.2026

This week, we're revisiting a previous conversation with Jon Koch, CEO, and Brian Lawrence, CFO and President, as they share their perspective on what’s next for CTI as the organization enters a new phase of growth. They reflect on CTI’s legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials. From scaling capabilities and investing...

Small Wins, Big Impact: Lessons from Pediatric Oncology 25.06.2026

What does it take to design clinical trials that truly put patients first—especially when those patients are children? In this episode of Moving Medicine Forward , Dr. Radhika Peddinti, Medical Director at CTI, discusses her journey from pediatric hematology/oncology at the bedside to shaping clinical research at a global scale. Drawing on more than two decades of experience caring for children an...

Biorepositories in Action: Protecting the Integrity of Every Sample 17.06.2026

In this episode, we’re joined by Rafael Miñana Prieto, Senior Manager of Operations for Laboratory Services at CTI, who oversees global biorepository operations across the U.S. and Europe. He walks through the full specimen lifecycle—from kit design and sample collection to storage, retrieval, and delivery—and explains why biological specimens are the foundation of clinical research. Rafael shares...

Engineering Organs: The Science Powering Xenotransplantation 11.06.2026

In this episode of Moving Medicine Forward , Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation and why it may represent a true turning point in medicine. From CRISPR-driven genetic engineering to breakthroughs in immunosuppression and scalable organ production, Dr. Fisher breaks down how decades of research are converging...

Adapting to Industry Rebound: The Next Phase of Clinical Trials 03.06.2026

What does a recovering clinical research market actually look like in 2026? In this episode, Joel White , Owner of Market Cap Consulting, and Ryan Gifford , Vice President, Global Laboratory Services, Business Development & Client Management at CTI, join us to unpack the state of the industry—from the rebound in biotech funding to the growing importance of execution, site relationships, and sm...

Ouça o podcast Moving Medicine Forward no Replaio

Rádio e podcasts em um só app - grátis e sem cadastro. Instale hoje e não perca o lançamento

Baixe no Google Play

O Replaio não é o publicador dos podcasts; os nomes dos programas, as capas e o áudio pertencem aos seus autores e são distribuídos por feeds RSS públicos